Search results

1. Investigation of molecular mechanisms of rapid antidepressant action of NLX-101, a biased agonist of the 5-HT1A receptor…

Principal investigator: prof. Mariusz Papp

Instytut Farmakologii PAN

Call: OPUS 18, Panel: NZ7

2. The role of the immune checkpoints in the pathomechanism of depressive disorders.

Principal investigator: prof. Marta Wanda Kubera

Instytut Farmakologii PAN

Call: OPUS 22, Panel: NZ6

3. Prenatal exposure to glucocorticoids as a risk factor for depression - the importance of epigenetic mechanisms in the br…

Principal investigator: dr Katarzyna Elżbieta Głombik

Instytut Farmakologii PAN

Call: SONATA 16, Panel: NZ7

4. Is it worth turning depressed mood into the joke? The effect of humor on emotion regulation in vulnerability to depressi…

Principal investigator: dr Anna Magdalena Braniecka

Szkoła Wyższa Psychologii Społecznej w Warszawie, Wydział Psychologii

Call: SONATA 8, Panel: HS6

5. Immersive virtual reality therapy combined with guided breathing exercises as a supportive intervention for reducing dep…

Principal investigator: Magdalena Anna Nowak

Politechnika Opolska

Call: PRELUDIUM 24, Panel: NZ7

6. Mechanisms of Antidepressant Action of Psilocybin: The Role of 5-HT2B-5-HT1A Receptor Dimerization and GSK-3β Activation…

Principal investigator: dr hab. Agata Faron-Górecka

Instytut Farmakologii PAN

Call: OPUS 27, Panel: NZ7

7. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista…

Principal investigator: prof. Mariusz Papp

Instytut Farmakologii PAN

Call: OPUS 26, Panel: NZ7

8. Plasticity of neuroanatomically identified synaptic inputs and functions of the dorsal raphe nucleus in an animal model …

Principal investigator: prof. Krzysztof Tokarski

Instytut Farmakologii PAN

Call: OPUS 25, Panel: NZ4

9. The impact of pregnant rat dietary supplementation with Lactobacillus rhamnosus JB-1 bacteria on depression-related symp…

Principal investigator: dr Agata Chudzik

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 20, Panel: NZ4

10. Interplay between neuroplasticity and CC/CXC chemokine inflamatory pathways in depression.

Principal investigator: prof. Tomasz Adam Śliwiński

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 21, Panel: NZ7

11. Neurochemical basis of antidepressive properties of psychedelics in rodent model of depression

Principal investigator: prof. Krystyna Czesława Gołembiowska

Instytut Farmakologii PAN

Call: OPUS 19, Panel: NZ7

12. Metabolic Chronopathology in Depression: Functional Astrocyte-Neuron Interactions in the Cellular Model of Glucocorticoi…

Principal investigator: dr Michał Wiesław Ślęzak

Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

Call: POLS, Panel: NZ3

13. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan…

Principal investigator: prof. Andrzej Mikołaj Pilc

Instytut Farmakologii PAN

Call: OPUS 19, Panel: NZ7

14. Zinc deficient diet as a trigger for treatment-resistant depression in chronically stressed mice. Understanding the mech…

Principal investigator: dr hab. Bernadeta Szewczyk

Instytut Farmakologii PAN

Call: OPUS 19, Panel: NZ5

15. Relationship between depression, anxiety and Social Networking Sites addiction: The role of Fear of Missing Out and pref…

Principal investigator: Julia Maria Balcerowska

Uniwersytet Gdański, Wydział Nauk Społecznych

Call: PRELUDIUM 19, Panel: HS6

16. Neuronal and behavioral mechanisms of emotion regulation and autobiographical memory in borderline personality disorder …

Principal investigator: Maria Karolina Kulesza

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: ETIUDA 8, Panel: HS6

17. Targeting senescent brain cells to improve cognitive function in animal models of ageing and depression

Principal investigator: prof. Ewa Zofia Sikora

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: OPUS 18, Panel: NZ4

18. Time perspective and circadian rhythm disruptions as predictors of stress and postpartum depressive symptoms: A longitud…

Principal investigator: dr hab. Małgorzata Sobol

Uniwersytet Warszawski, Wydział Psychologii

Call: OPUS 18, Panel: HS6

19. Effect of therapy with selective serotonin reuptake inhibitors and physical exercise on blood brain barrier permeability…

Principal investigator: Marta Anna Małkiewicz

Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej

Call: PRELUDIUM 17, Panel: NZ5

20. Therapeutic potential of biased 5-HT7 receptor ligands in the treatment of depression

Principal investigator: prof. Paweł Maria Zajdel

Uniwersytet Jagielloński, Collegium Medicum

Call: OPUS 17, Panel: NZ7

21. The labeling effect in prosocial behavior toward out-group members in the example of people diagnosed with depression

Principal investigator: Katarzyna Kulwicka

Szkoła Wyższa Psychologii Społecznej w Warszawie, Wydział Psychologii we Wrocławiu

Call: PRELUDIUM 17, Panel: HS6

22. Neuronal and behavioral mechanisms of emotion regulation and autobiographical memory in Borderline Personality Disorder …

Principal investigator: Maria Karolina Kulesza

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: PRELUDIUM 17, Panel: HS6

23. Seeing the world thorough rose colored glasses: How acute aerobic exercise influences emotional processing and emotional…

Principal investigator: dr Tomasz Stanisław Ligęza

Uniwersytet Jagielloński, Wydział Filozoficzny

Call: SONATINA 3, Panel: HS6

24. Novel pharmacological strategies for the treatment of depression

Principal investigator: dr hab. Katarzyna Młyniec

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Call: OPUS 16, Panel: NZ7

25. Small Changes - Huge Impact: The role of S-palmitoylation and S-nitrosylation interplay in the mice model of depression

Principal investigator: dr hab. Jakub Mateusz Włodarczyk

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: SONATA BIS 7, Panel: NZ4

26. Modulation of inflammatory processes using new agonists of the formyl peptide receptors ALX/FPR2 as a new therapeutic st…

Principal investigator: prof. Agnieszka Basta-Kaim

Instytut Farmakologii PAN

Call: HARMONIA 9, Panel: NZ7

27. Effectiveness of self-affirming implementation intentions to reduce anxiety and depression, and improve well-being in ps…

Principal investigator: Patryk Marek Łakuta

Szkoła Wyższa Psychologii Społecznej w Warszawie, Wydział Psychologii

Call: PRELUDIUM 13, Panel: HS6

28. The effects of thyroid hormones in the brain in an animal model of depression

Principal investigator: prof. Bogusława Budziszewska

Instytut Farmakologii PAN

Call: OPUS 13, Panel: NZ7

29. Role of oxidative stress and ceramide in the pathogenesis of depression and in the mechanizm of action of antidepressant…

Principal investigator: Justyna Józefa Brodowicz

Instytut Farmakologii PAN

Call: PRELUDIUM 12, Panel: NZ5

30. Sensitivity to negative feedback as a cognitive biomarker of depression in an animal model

Principal investigator: dr hab. Rafał Ryguła

Instytut Farmakologii PAN

Call: OPUS 12, Panel: NZ4

31. Patophysiology of depression: molecular regulation of melatonin homeostasis

Principal investigator: dr hab. Monika Paulina Dmitrzak-Węglarz

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

Call: OPUS 12, Panel: NZ5

32. The importance of interaction between NMDA and AMPA receptors and scaffolding proteins in the excitatory synaptic in the…

Principal investigator: dr hab. Magdalena Jolanta Sowa-Kućma

Uniwersytet Rzeszowski, Kolegium Nauk Medycznych

Call: OPUS 11, Panel: NZ7

33. Synthesis and pharmacological characterization of structurally diverse chemical analogues of compound PO-10 as multiple …

Principal investigator: dr hab. Agnieszka Zagórska

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Call: SONATA 11, Panel: NZ7

34. Molecular mechanisms of lithium action in depression and mania: animal model and clinical study in bipolar disorder

Principal investigator: prof. Joanna Wiktoria Twarowska-Hauser

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

Call: OPUS 11, Panel: NZ5

35. The effect of gratitude on psychological well-being and affect of women with breast cancer and women with depression.

Principal investigator: Joanna Tomczyk

Szkoła Wyższa Psychologii Społecznej w Warszawie, Wydział Psychologii

Call: PRELUDIUM 11, Panel: HS6

36. The role of inflammation, oxidative and nitrosative stress, tryptophan catabolites pathway and DNA base excision repair …

Principal investigator: dr hab. Tomasz Śliwiński

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 10, Panel: NZ7

37. An association between systemic inflammation and post-stroke depressive symptoms.

Principal investigator: prof. Tomasz Dziedzic

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: OPUS 10, Panel: NZ4

38. Role of the NLRP3 inflammasome in the mechanisms of action of antidepressant drugs - study in an animal model of depress…

Principal investigator: dr Ewa Izabela Trojan

Instytut Farmakologii PAN

Call: PRELUDIUM 9, Panel: NZ7

39. The role of the factors involved in the brain glucose metabolism in the model of obesity and depression comorbidity

Principal investigator: prof. Bogusława Budziszewska

Instytut Farmakologii PAN

Call: OPUS 7, Panel: NZ7

40. Pessimism as cognitive biomarker of depression in animal model

Principal investigator: dr hab. Rafał Ryguła

Instytut Farmakologii PAN

Call: OPUS 7, Panel: NZ4

41. Mitochondrial DNA damage and repair in depression

Principal investigator: Piotr Lech Czarny

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: PRELUDIUM 7, Panel: NZ7

42. The role of chemokines in the pathogenesis of depression and molecular mechanism of action of antidepressants.

Principal investigator: prof. Agnieszka Basta-Kaim

Instytut Farmakologii PAN

Call: OPUS 5, Panel: NZ7

43. Transcription factor MeCP2 as an intracellular object of study on the mechanism of depression and as a potential pharmac…

Principal investigator: dr Magdalena Jolanta Sowa-Kućma

Instytut Farmakologii PAN

Call: SONATA 5, Panel: NZ7

44. On the mechanism of NMDA receptor changes in the treatment of depression.

Principal investigator: dr hab. Maria Teresa Radziwoń-Zaleska

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Call: OPUS 4, Panel: NZ7

45. The role of dominant controlling functions over stimulation in cognitive performance in anxiety and depression.

Principal investigator: dr hab. Małgorzata Fajkowska

Instytut Psychologii PAN

Call: SONATA BIS 2, Panel: HS6

46. Role of the endocannabionoid system in the pathogenesis of depression and in the mechanism of action of antidepressant d…

Principal investigator: prof. Małgorzata Maria Filip

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Call: OPUS 3, Panel: NZ7

47. Evaluation of the role of subpopulations of T lymphocytes (Treg: CD4+CD25+, CD4+CD25- i Teff: Th2) in depression using p…

Principal investigator: dr Sylwia Kędracka-Krok

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: OPUS 3, Panel: NZ4

48. Application of lipidomic methods in depression diagnosis

Principal investigator: dr Agatha Anna Grela

Uniwersytet Jagielloński, Wydział Chemii

Call: PRELUDIUM 3, Panel: ST4

49. Moral - theological aspect of depression.

Principal investigator: Magdalena Kosowska

Uniwersytet Papieski Jana Pawła II w Krakowie, Wydział Teologiczny

Call: PRELUDIUM 1, Panel: HS1

50. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud…

Principal investigator: prof. Gabriel Piotr Nowak

Instytut Farmakologii PAN

Call: OPUS 28, Panel: NZ7

Projects search